TruBridge Zukünftiges Wachstum
Future Kriterienprüfungen 3/6
TruBridge wird ein jährliches Gewinn- und Umsatzwachstum von 25% bzw. 4.8% prognostiziert. Der Gewinn pro Aktie wird voraussichtlich wachsen um 32.7% pro Jahr. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich 5.3% betragen.
Wichtige Informationen
25.0%
Wachstumsrate der Gewinne
32.73%
EPS-Wachstumsrate
| Healthcare Services Gewinnwachstum | 22.3% |
| Wachstumsrate der Einnahmen | 4.8% |
| Zukünftige Eigenkapitalrendite | 5.31% |
| Analystenabdeckung | Low |
| Zuletzt aktualisiert | 15 May 2026 |
Jüngste Aktualisierungen zum künftigen Wachstum
Recent updates
Narrativ-Update • Apr 17
TBRG: Potential IKS Deal And EHR Execution Will Shape Future Re Rating
TruBridge's analyst fair value estimate has shifted from $21.00 to $22.00 as analysts update their models around potential IKS-related opportunities, as well as recent mixed price target moves across the Street. Analyst Commentary Bullish Takeaways Bullish analysts point to the potential IKS transaction as aligned with TruBridge's ongoing review of its business.
Neues Narrativ • Apr 16
AI And Global Delivery Expansion Will Reshape Rural Hospital Solutions Over The Next Decade
Catalysts About TruBridge TruBridge provides revenue cycle, financial health and patient care software and services to hospitals, with a focus on rural and community facilities. What are the underlying business or industry changes driving this perspective?Seeking Alpha • Apr 14
TruBridge: Potential Takeover Target, Upside Fundamentally Supported
Summary TruBridge, Inc. is undergoing an operational turnaround with margin expansion, rising EBITDA, and a shift to high-quality recurring revenue. A potential $600 million takeover by Inventurus Knowledge Systems offers a 36–40% premium to current prices but introduces binary deal risk. TBRG’s recurring revenue remains high at 94%, with stable cash flows and improved profitability despite flat top-line growth. The implied takeover valuation aligns with sector multiples, suggesting the upside is fundamentally supported, not purely speculative. Read the full article on Seeking AlphaNarrativ-Update • Apr 02
TBRG: Revenue Cycle Momentum And EHR Stability Will Support Future Re Rating
Analysts have trimmed their price targets on TruBridge, with the average moving from about $22.67 to $21.00 as they weigh a slightly higher discount rate, modestly different revenue growth and margin assumptions, and a lower future P/E multiple against the company's mix of Revenue Cycle Management growth potential and stable Electronic Health Records operations. Analyst Commentary Recent research updates on TruBridge reflect a mix of optimism around the business model and caution around execution and valuation.
Neues Narrativ • Apr 02
AI Expansion And Global Delivery Shift Will Shape A Steady But Capped Future
Catalysts About TruBridge TruBridge provides revenue cycle, financial health and electronic health record solutions to hospitals and healthcare providers, with a particular focus on rural and community facilities. What are the underlying business or industry changes driving this perspective?Analyseartikel • Feb 12
Returns At TruBridge (NASDAQ:TBRG) Appear To Be Weighed Down
What are the early trends we should look for to identify a stock that could multiply in value over the long term...Narrativ-Update • Jan 28
TBRG: Revenue Cycle Focus And EHR Stability Will Test Execution Outcomes
Narrative Update The analyst price target for TruBridge has shifted modestly higher to about $22.67 per share, supported by analysts citing the potential of its Revenue Cycle Management focus alongside a steadier Electronic Health Records business, while still calling out execution risk after recent periods of low growth. Analyst Commentary Recent research points to a mixed but constructive view on TruBridge, with analysts focusing on the shift toward Revenue Cycle Management and the steadier Electronic Health Records business when considering valuation and execution risk.Narrativ-Update • Jan 12
TBRG: Revenue Cycle Realignment And EHR Stability Will Require Steady Execution
Narrative Update The analyst price target for TruBridge now centers around US$23, a modest lift from the prior US$22.60. Analysts point to the potential of the Revenue Cycle Management opportunity alongside a steadier Electronic Health Records business, while still flagging execution risk after recent periods of low growth.Narrativ-Update • Dec 17
TBRG: Revenue Cycle Shift Will Demand Proven Execution Before Rerating
Analysts raised their price target on TruBridge modestly, citing improving growth prospects from the company’s shift toward revenue cycle management as evidence builds of its long-term earnings potential. Analyst Commentary Bullish Takeaways Bullish analysts view the company’s realignment toward revenue cycle management as a structurally higher growth opportunity compared with its legacy clinical software offerings.Narrativ-Update • Dec 03
TBRG: Revenue Cycle Pivot Will Require Clear Execution Evidence In 2025
Analysts have nudged their price target on TruBridge slightly higher to approximately $22.60 per share. This reflects increased confidence that the company’s shift toward revenue cycle management can unlock more attractive, evidence-based growth than its legacy clinical software focus.Narrativ-Update • Nov 19
TBRG: Measured Optimism Will Depend On Evidence Of Execution In 2025
TruBridge's analyst price target has been revised downward from $24.75 to $22.60. Analysts cite recent coverage reflecting cautious optimism about the company's strategic shift toward revenue cycle management, while awaiting clearer evidence of execution before turning more positive.Analyseartikel • Nov 14
Solid Earnings Reflect TruBridge's (NASDAQ:TBRG) Strength As A Business
Even though TruBridge, Inc.'s ( NASDAQ:TBRG ) recent earnings release was robust, the market didn't seem to notice. We...Narrativ-Update • Aug 15
AI And India Hub Will Boost Future Healthcare Efficiency
Despite a notable improvement in TruBridge’s net profit margin and a significant decline in its future P/E ratio, the consensus analyst price target has been sharply revised down from $29.25 to $24.75. What's in the News TruBridge lowered its full-year 2025 revenue guidance to $345 million-$350 million from a previous range of $345 million-$360 million; third quarter 2025 revenue is forecasted at $85 million-$87 million.Neues Narrativ • May 31
Digital Automation And AI Will Drive Healthcare Transformation
Increased AI-driven automation, expanded SaaS offerings, and digital transformation are expected to boost operational efficiency, recurring revenue growth, and earnings quality.Analyseartikel • Feb 14
Would TruBridge (NASDAQ:TBRG) Be Better Off With Less Debt?
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...Analyseartikel • Jan 17
TruBridge, Inc. (NASDAQ:TBRG) Shares Fly 27% But Investors Aren't Buying For Growth
TruBridge, Inc. ( NASDAQ:TBRG ) shares have continued their recent momentum with a 27% gain in the last month alone...Analyseartikel • Nov 13
TruBridge, Inc.'s (NASDAQ:TBRG) Business And Shares Still Trailing The Industry
TruBridge, Inc.'s ( NASDAQ:TBRG ) price-to-sales (or "P/S") ratio of 0.7x might make it look like a buy right now...Analyseartikel • Aug 05
Is TruBridge (NASDAQ:TBRG) Using Too Much Debt?
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...Analyseartikel • May 25
Is TruBridge, Inc. (NASDAQ:TBRG) Trading At A 38% Discount?
Key Insights The projected fair value for TruBridge is US$16.15 based on 2 Stage Free Cash Flow to Equity Current share...Analyseartikel • Feb 23
Computer Programs and Systems (NASDAQ:CPSI) Might Be Having Difficulty Using Its Capital Effectively
If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...Analyseartikel • Sep 06
What Does Computer Programs and Systems, Inc.'s (NASDAQ:CPSI) Share Price Indicate?
Computer Programs and Systems, Inc. ( NASDAQ:CPSI ), is not the largest company out there, but it received a lot of...Gewinn- und Umsatzwachstumsprognosen
| Datum | Umsatz | Gewinne | Freier Cashflow | Bargeld aus operativen Tätigkeiten | Durchschn. Anz. Analysten |
|---|---|---|---|---|---|
| 12/31/2028 | 407 | 16 | N/A | N/A | 1 |
| 12/31/2027 | 371 | 16 | 36 | 63 | 5 |
| 12/31/2026 | 351 | 26 | 30 | 57 | 2 |
| 3/31/2026 | 346 | 4 | 30 | 47 | N/A |
| 12/31/2025 | 347 | 4 | 20 | 37 | N/A |
| 9/30/2025 | 347 | 3 | 21 | 37 | N/A |
| 6/30/2025 | 345 | -11 | 16 | 34 | N/A |
| 3/31/2025 | 345 | -18 | 22 | 39 | N/A |
| 12/31/2024 | 342 | -20 | 13 | 31 | N/A |
| 9/30/2024 | 337 | -59 | -10 | 10 | N/A |
| 6/30/2024 | 335 | -54 | -18 | 3 | N/A |
| 3/31/2024 | 334 | -52 | -33 | -10 | N/A |
| 12/31/2023 | 337 | -47 | -22 | -1 | N/A |
| 9/30/2023 | 337 | -1 | -7 | 15 | N/A |
| 6/30/2023 | 337 | 5 | 1 | 23 | N/A |
| 3/31/2023 | 335 | 11 | 9 | 30 | N/A |
| 12/31/2022 | 327 | 16 | 13 | 32 | N/A |
| 9/30/2022 | 317 | 18 | 26 | 43 | N/A |
| 6/30/2022 | 305 | 19 | 19 | 34 | N/A |
| 3/31/2022 | 290 | 22 | 33 | 46 | N/A |
| 12/31/2021 | 281 | 18 | 37 | 48 | N/A |
| 9/30/2021 | 273 | 16 | 42 | 51 | N/A |
| 6/30/2021 | 272 | 18 | 51 | 57 | N/A |
| 3/31/2021 | 263 | 14 | 50 | 55 | N/A |
| 12/31/2020 | 264 | 14 | 42 | 49 | N/A |
| 9/30/2020 | 268 | 22 | 45 | 51 | N/A |
| 6/30/2020 | 269 | 20 | 46 | 51 | N/A |
| 3/31/2020 | 275 | 20 | 39 | 43 | N/A |
| 12/31/2019 | 275 | 20 | N/A | 44 | N/A |
| 9/30/2019 | 276 | 16 | N/A | 35 | N/A |
| 6/30/2019 | 277 | 18 | N/A | 34 | N/A |
| 3/31/2019 | 279 | 17 | N/A | 29 | N/A |
| 12/31/2018 | 280 | 17 | N/A | 24 | N/A |
| 9/30/2018 | 286 | -11 | N/A | 20 | N/A |
| 6/30/2018 | 284 | -15 | N/A | 16 | N/A |
| 3/31/2018 | 284 | -13 | N/A | 17 | N/A |
| 12/31/2017 | 277 | -17 | N/A | 24 | N/A |
| 9/30/2017 | 263 | 6 | N/A | 23 | N/A |
| 6/30/2017 | 261 | 5 | N/A | 26 | N/A |
| 3/31/2017 | 262 | 6 | N/A | 11 | N/A |
| 12/31/2016 | 267 | 4 | N/A | 2 | N/A |
| 9/30/2016 | 247 | 5 | N/A | 2 | N/A |
| 6/30/2016 | 227 | 7 | N/A | 5 | N/A |
| 3/31/2016 | 206 | 11 | N/A | 18 | N/A |
| 12/31/2015 | 182 | 18 | N/A | 31 | N/A |
| 9/30/2015 | 184 | 21 | N/A | 39 | N/A |
| 6/30/2015 | 193 | 27 | N/A | 42 | N/A |
Analystenprognosen zum zukünftigen Wachstum
Einkommen vs. Sparrate: TBRGDas prognostizierte Gewinnwachstum (25% pro Jahr) liegt über der Sparquote (3.5%).
Ertrag vs. Markt: TBRGDie Erträge des Unternehmens (25% pro Jahr) werden voraussichtlich schneller wachsen als der Markt US (16.8% pro Jahr).
Hohe Wachstumserträge: TBRGEs wird erwartet, dass die Erträge des Unternehmens in den nächsten 3 Jahren erheblich steigen werden.
Einnahmen vs. Markt: TBRGDie Einnahmen des Unternehmens (4.8% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt US (11.7% pro Jahr).
Hohe Wachstumseinnahmen: TBRGDie Einnahmen des Unternehmens (4.8% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.
Wachstumsprognosen für den Gewinn je Aktie
Künftige Eigenkapitalrendite
Künftige Eigenkapitalrendite: TBRGDie Eigenkapitalrendite des Unternehmens wird in 3 Jahren voraussichtlich niedrig sein (5.3%).
Wachstumsunternehmen entdecken
Unternehmensanalyse und Finanzdaten Status
| Daten | Zuletzt aktualisiert (UTC-Zeit) |
|---|---|
| Unternehmensanalyse | 2026/05/22 12:25 |
| Aktienkurs zum Tagesende | 2026/05/22 00:00 |
| Gewinne | 2026/03/31 |
| Jährliche Einnahmen | 2025/12/31 |
Datenquellen
Die in unserer Unternehmensanalyse verwendeten Daten stammen von S&P Global Market Intelligence LLC. Die folgenden Daten werden in unserem Analysemodell verwendet, um diesen Bericht zu erstellen. Die Daten sind normalisiert, was zu einer Verzögerung bei der Verfügbarkeit der Quelle führen kann.
| Paket | Daten | Zeitrahmen | Beispiel US-Quelle * |
|---|---|---|---|
| Finanzdaten des Unternehmens | 10 Jahre |
| |
| Konsensschätzungen der Analysten | +3 Jahre |
|
|
| Marktpreise | 30 Jahre |
| |
| Eigentümerschaft | 10 Jahre |
| |
| Verwaltung | 10 Jahre |
| |
| Wichtige Entwicklungen | 10 Jahre |
|
* Beispiel für US-Wertpapiere, für nicht-US-amerikanische Wertpapiere werden gleichwertige regulatorische Formulare und Quellen verwendet.
Sofern nicht anders angegeben, beziehen sich alle Finanzdaten auf einen Jahreszeitraum, werden aber vierteljährlich aktualisiert. Dies wird als Trailing Twelve Month (TTM) oder Last Twelve Month (LTM) Daten bezeichnet. Erfahren Sie mehr.
Analysemodell und Schneeflocke
Einzelheiten zu dem Analysemodell, mit dem dieser Bericht erstellt wurde, finden Sie auf unserer Github-Seite. Außerdem bieten wir Leitfäden zur Verwendung unserer Berichte und Tutorials auf YouTube an.
Erfahren Sie mehr über das Weltklasse-Team, das das Simply Wall St-Analysemodell entworfen und entwickelt hat.
Metriken für Industrie und Sektor
Unsere Branchen- und Sektionskennzahlen werden alle 6 Stunden von Simply Wall St berechnet. Details zu unserem Verfahren finden Sie auf Github.
Analysten-Quellen
TruBridge, Inc. wird von 23 Analysten beobachtet. 5 dieser Analysten hat die Umsatz- oder Gewinnschätzungen übermittelt, die als Grundlage für unseren Bericht dienen. Die von den Analysten übermittelten Daten werden im Laufe des Tages aktualisiert.
| Analyst | Einrichtung |
|---|---|
| Matthew Gillmor | Baird |
| Stephanie Davis | Barclays |
| Sean Dodge | BMO Capital Markets Equity Research |